Rapid-acting Treatments for Pediatric Depression and Suicidality: Where are We Now?
Brown University via Independent
-
115
-
- Write review
You’re only 3 weeks away from a new language
MIT Sloan: Lead AI Adoption Across Your Organization — Not Just Pilot It
Overview
Google, IBM & Meta Certificates — All 10,000+ Courses at 40% Off
One annual plan covers every course and certificate on Coursera. 40% off for a limited time.
Get Full Access
Jennifer B. Dwyer, MD, PhD
Co-Director Yale Pediatric Depression Program
Assistant Professor, Child Study Center and Dept of Radiology and Biomedical Imaging
Yale University
Syllabus
- Describe the proposed mechanism of action of novel rapid-acting anti-depressant and anti-suicidal pharmacotherapeutics
- Describe the state of the pediatric evidence base for rapid-acting treatments and to compare it with the adult evidence base
- Appreciate the unique developmental considerations that apply to testing and implementing novel therapeutics in the pediatric population